With the slowdown in world economic growth, the Peripheral Vascular Diagnostic Systems Industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Peripheral Vascular Diagnostic Systems market size to maintain the average annual growth rate of XXX from XXX million $ in 2014 to XXX million $ in 2019, Stratagem Market Insights analysts believe that in the next few years, Peripheral Vascular Diagnostic Systems market size will be further expanded, we expect that by 2026, The market size of the Peripheral Vascular Diagnostic Systems will reach XXX million $.
Increasing prevalence of peripheral arterial diseases (PADs) is expected to propel the growth of the global peripheral vascular diagnostic systems market over the forecast period. For instance, according to the National Center for Biotechnology Information May 2018 data, over 200 million people suffer from PAD worldwide. Moreover, the high prevalence of atherosclerosis is also expected to aid in the growth of the market. For instance, according to a study appearing online in May 2018, in the journal Radiology, the prevalence of atherosclerosis is high in people considered to be at low to intermediate risk for cardiovascular disease.
Increasing cases of diabetes are expected to offer lucrative growth opportunities for players in the global peripheral vascular diagnostic systems market. For instance, according to the study, ‘Global Prevalence of Type 2 Diabetes over the Next Ten Years (2018-2028)’, published by the American Diabetes Association, 500 million people worldwide suffered from type 2 diabetes in 2018. Moreover, the growing preference for non-invasive procedures is also expected to aid in the growth of the market.
However, the high cost of peripheral artery diagnosis and the drawbacks of peripheral vascular diagnostic systems are expected to hamper the growth of the global peripheral vascular diagnostic systems market. For instance, the ankle-brachial index (ABI) has poor sensitivity in patients with calcified arteries and lacks localization capability.
Moreover, under-diagnosis in primary care is a major challenge in the growth of the market. This can be addressed by the development of new unobtrusive monitoring techniques.
The use of robotics in peripheral artery disease interventions is a major trend in the global peripheral vascular diagnostic systems market. For instance, Corindus Vascular Robotics offers Corpath 200 system and Hansen Medical offers Hansen system for the treatment of PAD with endovascular interventions.
Major players in the market are focused on product approval and launch to expand their product portfolio. For instance, in January 2020, Philips Healthcare launched the Zenition mobile C-arm platform, including a new Table Side User Interface and an extension integrating intravascular ultrasound. The platform improves treatment for peripheral vascular and coronary patients.
Key Takeaways:
- Increasing prevalence of the peripheral arterial disease is expected to augment the growth of the global peripheral vascular diagnostic systems market over the forecast period
- However, the high cost of peripheral artery diagnosis is expected to hinder the growth of the market
- Major players operating in the global peripheral vascular diagnostic systems market include Philips Healthcare, ArjoHuntleigh, Viasonix, OMRON Healthcare, Opto Circuits, ACI Medical Management, BioMedix, Dialog Devices, D.E. Hokanson, ELCAT, FUKUDA DENSHI, Koven Technology, LD Technology, and MGC Diagnostics
This Report covers the manufacturers' data, including: shipment, price, revenue, gross profit, interview record, business distribution, etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment, etc. cover different segment market sizes, both volume, and value. Also cover different industries client's information, which is very important for the manufacturers.
Section 1: Definition
Section (2 3): Manufacturer Detail
╼ ArjoHuntleigh
╼ Viasonix
╼ OMRON Healthcare
╼ Opto Circuits
╼ ACI Medical Management
╼ BioMedix
╼ Dialog Devices
╼ D.E. Hokanson
╼ ELCAT
╼ FUKUDA DENSHI
╼ Koven Technology
╼ LD Technology
╼ MGC Diagnostics
Section 4: Region Segmentation
╼ North America Country (United States, Canada)
╼ South America
╼ Asia Country (China, Japan, India, Korea)
╼ Europe Country (Germany, UK, France, Italy)
╼ Other Country (Middle East, Africa, GCC)
Section (5 6 7): Type Segmentation
Product Type Segmentation ➟
╼ Diabetes
╼ Critical Limb Ischemia
Industry Segmentation ➟
╼ ASCs
╼ Hospitals
╼ Physicians' Offices
Channel (Direct Sales, Distributor) Segmentation
Section 8: Trend (2019-2026)
Section 9: Product Type Detail
Section 10: Downstream Consumer
Section 11: Cost Structure
Section 12: Conclusion
Request Discount 
Inquire Before Buy
